A Texas lawmaker introduced a bill on Wednesday that would require the state to study the therapeutic potential of psilocybin, MDMA and ketamine in the treatment of certain mental health conditions.

The Drug Enforcement Administration (DEA) wants to know whether its prospective employees or contractors have used hemp or CBD—but only if they used it before December 20, 2018.

Cambridge, Massachusetts has become the latest city to decriminalize a wide range of psychedelics following a City Council vote on Wednesday.

Legalizing marijuana is more popular than implementing a national $15 minimum wage, rejoining the Paris climate agreement or establishing a pathway to citizenship for undocumented immigrants, according to a new poll of U.S. adults.

Magic mushrooms, or “shrooms,” are a type of mushroom containing psilocybin, a hallucinogenic compound.

A number of potential sector-wide catalysts for psychedelic stocks are already present or rapidly approaching.

Mind Cure has listed the warrants for trading from its recent financing. Warrants are valid until February 10, 2026, at an exercise price of CAD$0.80.

Psychedelic stock warrants have already produced some phenomenal gains for investors. Now a new series of 5-year warrants is trading.

Researchers are to begin trialing the use of the psychedelic drug DMT as a treatment for stroke patients, after preclinical studies on rats indicated that the substance could help the brain repair itself following injury.